Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
There is a growing body of evidence exploring the role of curcumin as a radioprotector against radiation-induced injury in normal tissues as well as a radiosensitizer in tumor cells. The aim of this study is to determine the efficacy of oral nanocurcumin in prostate cancer patients undergoing radiotherapy.
Epistemonikos ID: d1ba91a547eb1c9090870c0f13b899fcb75d2627
First added on: May 12, 2024